Carol Giltner Gallagher, Director at Atara Biotherapeutics, Inc. (ATRA), sold 1,183 shares at $16.30 ($19K) on 2016-02-17, disclosed to the SEC on 2016-02-18.
Scheduled sale ($19k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRA | SELL | 2018-06-19 | $112K | — | Filing → |
| ATRA | SELL | 2018-05-16 | $13K | — | Filing → |
| ATRA | SELL | 2018-02-20 | $110K | — | Filing → |